181 related articles for article (PubMed ID: 1350486)
21. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
Ruffolo RR; Feuerstein GZ
Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
[TBL] [Abstract][Full Text] [Related]
22. [Balanced beta--alpha-blocker treatment with carvedilol in mild-moderate arterial hypertension].
Perocchio M; Gigli G; Barra M; Sacchetti R; Vallebona A; Rosolen GA; Orlandi S
Minerva Cardioangiol; 1996 Mar; 44(3):115-21. PubMed ID: 8767610
[TBL] [Abstract][Full Text] [Related]
23. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy.
Metra M; Nardi M; Giubbini R; Dei Cas L
J Am Coll Cardiol; 1994 Dec; 24(7):1678-87. PubMed ID: 7963115
[TBL] [Abstract][Full Text] [Related]
24. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart.
Gilbert EM; Abraham WT; Olsen S; Hattler B; White M; Mealy P; Larrabee P; Bristow MR
Circulation; 1996 Dec; 94(11):2817-25. PubMed ID: 8941107
[TBL] [Abstract][Full Text] [Related]
25. Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
Giugliano D; Marfella R; Acampora R; Giunta R; Coppola L; D'Onofrio F
Diabetes Care; 1998 Apr; 21(4):631-6. PubMed ID: 9571355
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamic profile of carvedilol.
van Zwieten PA
Cardiology; 1993; 82 Suppl 3():19-23. PubMed ID: 8106159
[TBL] [Abstract][Full Text] [Related]
27. [Acute hemodynamic effects of the vasodilator beta blocker carvedilol in heart failure].
Buchwald A; Unterberg C; van der Does R; Wiegand V
Z Kardiol; 1990 Jun; 79(6):424-8. PubMed ID: 1974100
[TBL] [Abstract][Full Text] [Related]
28. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
Lund-Johansen P
Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
[TBL] [Abstract][Full Text] [Related]
29. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L
J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572
[TBL] [Abstract][Full Text] [Related]
30. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
[TBL] [Abstract][Full Text] [Related]
31. Carvedilol in ischaemic heart disease.
Prichard BN
Cardiology; 1993; 82 Suppl 3():34-9. PubMed ID: 8106163
[TBL] [Abstract][Full Text] [Related]
32. Acute haemodynamic effects of carvedilol (BM 14190), a new combined beta-adrenoceptor blocker and precapillary vasodilating agent, in hypertensive patients.
Eggertsen R; Andrén L; Sivertsson R; Hansson L
Eur J Clin Pharmacol; 1984; 27(1):19-22. PubMed ID: 6149128
[TBL] [Abstract][Full Text] [Related]
33. The role of alpha- and beta-adrenoceptor blockade in antihypertensive treatment.
van Zwieten PA
Clin Investig; 1992; 70 Suppl 1():S7-12. PubMed ID: 1350488
[TBL] [Abstract][Full Text] [Related]
34. Antihypertensive treatment in concomitant peripheral vascular disease: current experience and the potential of carvedilol.
Breckenridge A; Roberts DH
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S78-81. PubMed ID: 1721985
[TBL] [Abstract][Full Text] [Related]
35. Value of carvedilol in congestive heart failure secondary to coronary artery disease.
Das Gupta P; Broadhurst P; Raftery EB; Lahiri A
Am J Cardiol; 1990 Nov; 66(15):1118-23. PubMed ID: 1977300
[TBL] [Abstract][Full Text] [Related]
36. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
[TBL] [Abstract][Full Text] [Related]
37. Carvedilol and the kidney.
Dupont AG
Clin Investig; 1992; 70 Suppl 1():S127-31. PubMed ID: 1350479
[TBL] [Abstract][Full Text] [Related]
38. Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect.
Lund-Johansen P; Omvik P
Cardiovasc Drugs Ther; 1991 Jun; 5(3):605-15. PubMed ID: 1678963
[TBL] [Abstract][Full Text] [Related]
39. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
[TBL] [Abstract][Full Text] [Related]
40. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
Capomolla S; Febo O; Gnemmi M; Riccardi G; Opasich C; Caporotondi A; Mortara A; Pinna GD; Cobelli F
Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
